S
NVCR icon

Surevest’s NovoCure NVCR Stock Holding History

Surevest’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$24K Hold
320
– – 0.01% 229
2022
Q2 		$22K Hold
320
– – 0.01% 255
2022
Q1 		$27K Hold
320
– – 0.01% 218
2021
Q4 		$24K Buy
+320
New +$32.1K 0.01% 232

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Surevest's NVCR Position: Q3 2022 in Review

Surevest held its NovoCure (NVCR) position steady in Q3 2022 at 320 shares worth $24K. The position accounts for 0.01% of the portfolio, ranked #229.

Surevest first reported a position in NVCR in Q4 2021 and has held it in 4 quarters since. The position peaked at $27K in Q1 2022. 303 funds tracked by Wall St. Rank hold NVCR as of Q3 2022.

  • Surevest held 320 shares of NovoCure worth $24K as of Q3 2022.
  • Surevest left its NovoCure share count unchanged in Q3 2022.
  • NovoCure made up 0.01% of Surevest's portfolio in Q3 2022, its #229 holding.
  • Surevest first reported a position in NovoCure in Q4 2021 and has held it in 4 quarters since.
  • Surevest's NovoCure position peaked at $27K in Q1 2022.
  • 303 funds tracked by Wall St. Rank held NovoCure as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.